Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

José-Angel Hernández-Rivas

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|October 24, 2007
Primary laryngeal T/NK-cell lymphoma, nasal-type: an unusual location for an aggressive subtype of extranodal lymphomaJuan C Tardío, Amalia Moreno, Cecilia Pérez, et al.
International Journal of Hematology|July 2, 2017
Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practiceTomás José González-López, Fernando Fernández-Fuertes, José Angel Hernández-Rivas, et al.
European Journal of Haematology|December 17, 2019
Use of eltrombopag for patients 65 years old or older with immune thrombocytopeniaTomás José González-López, Blanca Sánchez-González, Isidro Jarque, et al.
European Journal of Haematology|December 29, 2015
Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practiceTomás José González-López, María Teresa Alvarez-Román, Cristina Pascual, et al.
Haematologica|October 1, 2016
Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyureaAlberto Alvarez-Larrán, Manuel Pérez-Encinas, Francisca Ferrer-Marín, et al.
American Journal of Hematology|November 18, 2014
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopeniaTomás José González-López, Cristina Pascual, María Teresa Álvarez-Román, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|October 24, 2007
Primary laryngeal T/NK-cell lymphoma, nasal-type: an unusual location for an aggressive subtype of extranodal lymphomaJuan C Tardío, Amalia Moreno, Cecilia Pérez, et al.
International Journal of Hematology|July 2, 2017
Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practiceTomás José González-López, Fernando Fernández-Fuertes, José Angel Hernández-Rivas, et al.
European Journal of Haematology|December 17, 2019
Use of eltrombopag for patients 65 years old or older with immune thrombocytopeniaTomás José González-López, Blanca Sánchez-González, Isidro Jarque, et al.
European Journal of Haematology|December 29, 2015
Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practiceTomás José González-López, María Teresa Alvarez-Román, Cristina Pascual, et al.
Haematologica|October 1, 2016
Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyureaAlberto Alvarez-Larrán, Manuel Pérez-Encinas, Francisca Ferrer-Marín, et al.
American Journal of Hematology|November 18, 2014
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopeniaTomás José González-López, Cristina Pascual, María Teresa Álvarez-Román, et al.
Pageof 1